OCATA THERAPEUTICS, INC. COMMON STOCK
OCAT
OCAT was delisted on the 9th of February, 2016.
60 hedge funds and large institutions have $31M invested in OCATA THERAPEUTICS, INC. COMMON STOCK in 2015 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 8 closing their positions.
1,328% more capital invested
Capital invested by funds: $2.17M → $31M (+$28.8M)
363% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 8
94% more funds holding
Funds holding: 31 → 60 (+29)
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
94% less call options, than puts
Call options by funds: $15K | Put options by funds: $262K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.04M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$5.76M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.93M |
| 4 |
VAM
Visium Asset Management
New York
|
+$4.64M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$319K |
| 2 |
Morgan Stanley
New York
|
-$239K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$170K |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$156K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$147K |
OCAT Hedge Fund Activity: Q2 2015 in Review
60 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) for Q2 2015, worth a combined $31M — up 1,328% from $2.17M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new OCAT positions and 8 closed out — a net gain of 29 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $6.04M. The largest seller was Millennium Management, exiting entirely with an estimated $319K sold.
- 60 institutional investors held OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) as of Q2 2015, up from 31 in Q1 2015.
- Funds reported $31M of OCATA THERAPEUTICS, INC. COMMON STOCK stock for Q2 2015, up 1,328% quarter-over-quarter.
- 37 funds opened new OCATA THERAPEUTICS, INC. COMMON STOCK positions in Q2 2015 and 8 closed out, a net change of +29 holders.
- The largest OCATA THERAPEUTICS, INC. COMMON STOCK buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $6.04M added.
- The largest OCATA THERAPEUTICS, INC. COMMON STOCK seller in Q2 2015 was Millennium Management, an estimated $319K sold.
Based on aggregated 13F filings for Q2 2015.